Our data are the first to show that inducible liver-specific knockdown of the mammalian homolog of the longevity gene Indy (Slc13a5) using second generation ASOs in rats ameliorates diet-induced hepatic steatosis, reduces plasma insulin, lipid and amino acid levels and improves hepatic insulin sensitivity independent of body weight. Here, SLC13A5 is linked to fatty liver disease.